DCF — GEISINGER MEDICAL CENTER
Enterprise Value: $367.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$367.8M
Enterprise Value
$67.5M
PV of Cash Flows
$300.3M
PV of Terminal Value
$483.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.6B | $75.5M | 5.0% | $-2.2M | $-2.0M |
| Year 2 | $1.7B | $94.6M | 6.0% | $10.3M | $8.6M |
| Year 3 | $1.7B | $114.7M | 7.0% | $23.6M | $17.8M |
| Year 4 | $1.8B | $127.0M | 7.0% | $31.0M | $21.2M |
| Year 5 | $1.8B | $135.4M | 7.0% | $35.4M | $22.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $367.8M. Terminal value accounts for 82% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.6B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.04132609893312304
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5